首页> 外文期刊>Endocrine journal >Computed tomography combined with confirmatory tests for the diagnosis of aldosterone-producing adenoma
【24h】

Computed tomography combined with confirmatory tests for the diagnosis of aldosterone-producing adenoma

机译:计算断层扫描结合诊断醛固酮的腺瘤的确诊试验

获取原文
       

摘要

Primary aldosteronism (PA) is the most common cause of secondary hypertension, and a simpler non-invasive method for identification of aldosterone-producing adenoma (APA) is required to improve the standard of medical treatment for PA patients. We retrospectively analyzed the clinical data of hypertensive patients with an aldosterone/renin ratio (ARR) ≥30 (ng/dL)/(ng/mL/h), and surgical and/or adrenal venous sampling (AVS) results served as the gold standard for APA diagnosis. The study aimed to determine whether positive CCT and SIT results plus a unilateral adrenal nodule found by CT allow unambiguous identification of an APA with high diagnostic specificity. Clinical data from 71 APA and 47 non-APA patients were collected, and logistic regression analysis was performed to construct models. Receiver operating characteristic (ROC) curves were used to analyze the efficacy of diagnostic tests. The areas under the ROC curves (AUCs) were similar between the post-SIT plasma aldosterone concentration (PAC) and post-CCT PAC ( p 0.05). The optimal post-SIT and post-CCT PAC cutoff values were 17.2 and 21.2 ng/dL, respectively. Positive CT findings combined with a post-SIT PAC 17.2 ng/dL or post-CCT PAC 21.2 ng/dL provided specificities of 97.8% and 95.7% for predicting APA, respectively. Logistic diagnostic models 1 (M1, CT finding + post-SIT PAC) and 2 (M2, CT finding + post-CCT PAC) were built, which showed equivalent diagnostic value (AUC = 0.959 and 0.932, respectively) ( p 0.05). The models combining CT findings with post-SIT PACs or post-CCT PACs represent an easier method to distinguish APA patients from other hypertensive patients with positive upright ARR results, especially in primary care where AVS may be unavailable.
机译:原发性醛固酮(PA)是继发性高血压最常见的原因,需要更简单的非侵入性方法,用于鉴定产生醛固酮的腺瘤(APA)来改善PA患者的医疗标准。回顾性地分析了醛固酮/肾素比(ARR)≥30(NG / DL)/(NG / ML / H)的高血压患者的临床数据,以及手术和/或肾上腺静脉采样(AVS)结果用作金色APA诊断标准。该研究旨在判断阳性CCT和SIT结果是否加上CT发现的单侧肾上腺结节,允许明确鉴定具有高诊断特异性的APA。收集来自71 APA和47名非APA患者的临床资料,并进行逻辑回归分析构建模型。接收器操作特征(ROC)曲线用于分析诊断测试的疗效。 ROC曲线(AUCS)下的区域在后静血浆醛固酮浓度(PAC)和CCT后PAC(P> 0.05)之间相似。最佳的后静置和后CCT PAC截止值分别为17.2和21.2ng / dl。阳性CT表现与后位PAC& 17.2ng / dl或后CCT PAC& 21.2 Ng / DL分别提供97.8%和95.7%的特异性预测APA。建立了物流诊断模型1(M1,CT发现+后PAC)和2(M2,CT发现+后CCT PAC),其显示出等效的诊断值(AUC = 0.959和0.932)(P> 0.05 )。将CT调查结果与SIT SIT PACS或CCT PACS组合的模型代表了一种更简单的方法,可以将APA患者与其他高血压患者区分开具有正直直立的ARR结果,尤其是初级保健,其中AVS可能无法使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号